GreenLight Biosciences Holdings PBC Warrant (GRNAW)
$0.02
As on 21-Jul-2023 12:10EDT
Market cap
--
Revenue (TTM)
--
P/E Ratio
--
P/B Ratio
--
Div. Yield
--
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
--
-
ROE
--
-
ROCE
--
-
Industry P/E
--
-
EV/EBITDA
--
-
Debt to Equity
--
-
Book Value
--
-
EPS
--
-
Face value
--
-
Shares outstanding
--
Years Aggregate
CFO
$--
EBITDA
$--
Net Profit
$--
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
GreenLight Biosciences Holdings PBC Warrant (GRNAW)
| -74.1 | -8.3 | -49.7 | -91.2 | -- | -- | -- |
|
BSE Sensex*
| -9.6 | -2.7 | 2.9 | -5.0 | 5.4 | 5.7 | 10.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Shareholding Pattern
View DetailsAbout GreenLight Biosciences Holdings PBC Warrant (GRNAW)
GreenLight Biosciences Holdings, a biotechnology company, manufactures and sells ribonucleic acid (RNA) products for human health and agriculture applications. Its products for human health include mRNA vaccines and therapeutics; and agricultural RNA... products to protect honeybees and crops. The company was founded in 2008 and is headquartered in Medford, Massachusetts. Read more
-
Co-Founder, Pres, CEO & Director
Dr. Andrey Juan Zarur Ph.D.
-
Co-Founder, Pres, CEO & Director
Dr. Andrey Juan Zarur Ph.D.
-
Headquarters
Medford, MA
-
Website
FAQs for GreenLight Biosciences Holdings PBC Warrant (GRNAW)
What is the current share price of GreenLight Biosciences Holdings PBC Warrant (GRNAW) Today?
The share price of GreenLight Biosciences Holdings PBC Warrant (GRNAW) is $0.02 (NASDAQ) as of 21-Jul-2023 12:10 EDT. GreenLight Biosciences Holdings PBC Warrant (GRNAW) has given a return of -91.2% in the last 1 years.
What is the current PB & PE ratio of GreenLight Biosciences Holdings PBC Warrant (GRNAW)?
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2022 |
-67.15 |
233.41 |
2021 |
-- |
-- |
2020 |
-- |
-- |
2019 |
-- |
-- |
2022 |
-67.15 |
233.41 |
What is the 52 Week High and Low of GreenLight Biosciences Holdings PBC Warrant (GRNAW)?
The 52-week high and low of GreenLight Biosciences Holdings PBC Warrant (GRNAW) are Rs -- and Rs -- as of 05-Sep-2026.
What is the market cap of GreenLight Biosciences Holdings PBC Warrant (GRNAW)?
GreenLight Biosciences Holdings PBC Warrant (GRNAW) has a market capitalisation of -- as on 21-Jul-2023. As per SEBI classification, it is a company.
Should I invest in GreenLight Biosciences Holdings PBC Warrant (GRNAW)?
Before investing in GreenLight Biosciences Holdings PBC Warrant (GRNAW), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.